Mar. Drugs 2013, 11(11), 4267-4278; doi:10.3390/md11114267

Cytotoxic Effects of Fucoidan Nanoparticles against Osteosarcoma

1,2email, 1,3email, 4email, 5email and 1,* email
Received: 6 September 2013; in revised form: 18 October 2013 / Accepted: 18 October 2013 / Published: 30 October 2013
(This article belongs to the Special Issue Marine Compounds and Cancer)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: In this study, we analyzed the size-dependent bioactivities of fucoidan by comparing the cytotoxic effects of native fucoidan and fucoidan lipid nanoparticles on osteosarcoma in vitro and in vivo. In vitro experiments indicated that nanoparticle fucoidan induced apoptosis of an osteosarcoma cell line more efficiently than native fucoidan. The more potent effects of nanoparticle fucoidan, relative to native fucoidan, were confirmed in vivo using a xenograft osteosarcoma model. Caco-2 cell transport studies showed that permeation of nanoparticle fucoidan was higher than native fucoidan. The higher bioactivity and superior bioavailability of nanoparticle fucoidan could potentially be utilized to develop novel therapies for osteosarcoma.
Keywords: fucoidan; nanoparticle; osteosarcoma; apoptosis; lung metastasis
PDF Full-text Download PDF Full-Text [1177 KB, uploaded 30 October 2013 12:20 CET]

Export to BibTeX |

MDPI and ACS Style

Kimura, R.; Rokkaku, T.; Takeda, S.; Senba, M.; Mori, N. Cytotoxic Effects of Fucoidan Nanoparticles against Osteosarcoma. Mar. Drugs 2013, 11, 4267-4278.

AMA Style

Kimura R, Rokkaku T, Takeda S, Senba M, Mori N. Cytotoxic Effects of Fucoidan Nanoparticles against Osteosarcoma. Marine Drugs. 2013; 11(11):4267-4278.

Chicago/Turabian Style

Kimura, Ryuichiro; Rokkaku, Takayoshi; Takeda, Shinji; Senba, Masachika; Mori, Naoki. 2013. "Cytotoxic Effects of Fucoidan Nanoparticles against Osteosarcoma." Mar. Drugs 11, no. 11: 4267-4278.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert